P.A. Lee , F. Pathan , B.S. Daniel
There is a strong interaction between cardiac medications
and dermatology. Cardiac medications are often used
to treat dermatological conditions including vasculitis,
Raynaud’s phenomenon, haemangiomas and hyperhidrosis.
Cardiac medications are known to worsen and trigger some
dermatological conditions such as beta-blockers in psoriasis.
More recently, novel antiplatelet and antithrombotic
agents pose bleeding risks, given their characteristics of
limited reversal and monitoring.
This presentation reviews the use and evidence behind
cardiac medications in dermatologic conditions. It also
reviews the literature about newer antiplatelet and
antithrombotic medications which have an impact on dermatological
surgery and outlines the guidelines for stopping
and reversal of these agents.